Prot# C-728: An Open-Label, Multictr Study to Eval. the Safety and Tolerability of Intramuscular Admin. of Alefacept (LFA-3/IgG1 Fusion Protein) in Subjects with Chronic Plaque Psoriasis who have Completed Studies C99-717 or C99-712